Impact of Therapeutic Footwear and Plantar Orthoses on Diabetic Neuropathic Foot in Quality of Life and Functionality
1 other identifier
interventional
43
1 country
1
Brief Summary
This study determines the effectiveness of plantar orthoses and custom-made orthopedic footwear in functional level and quality of life of persons with diabetes type 2 and diabetic peripheral neuropathy. This study is important due the loss of protective sensation, feet are vulnerable to minor trauma caused by plantar pressure as well as mechanical and thermal injuries. Thus, Plantar Orthoses become necessary to reduce PP and align the foot. Additionally, it is known that footwear is the most frequent cause of diabetic foot injury, since ulceration is frequently a consequence of the continuous trauma provoked by inadequate footwear. For a higher efficacy in the treatment of the foot, it is also necessary to use custom-made orthopedic footwear, indicated in the treatment of foot pathologies. The lack of studies that evaluate the impact of this treatment on clinical measures such as quality of life and functional level, led to the development of this study, comparing a standard treatment (standard footwear and plantar orthoses) with an optimal treatment suggested in diabetic foot guidelines (therapeutic footwear and plantar orthoses).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable diabetes-mellitus-type-2
Started Mar 2017
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 13, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 4, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 21, 2018
CompletedFirst Submitted
Initial submission to the registry
October 15, 2020
CompletedFirst Posted
Study publicly available on registry
October 28, 2020
CompletedOctober 30, 2020
October 1, 2020
10 months
October 15, 2020
October 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (8)
Change the Quality of Life
Significantly change any subscore or total score of Medical Outcomes Study 36-item Short-Form Health Survey instrument, that was use it to assess quality of life. Instrument scores can range between 0 - 100. Higher values mean better self-perception of quality of life.
4 months
Change the Performance of Lower Extremity Functional Scale
Change at least 9 points in Lower Extremity Functional Scale (minimum change for clinically relevant functional improvement). Instrument scores can range between 0 - 80. Higher values mean better functionality.
4 months
Change the Functional Reach Test performance
Significantly change the maximum distance (cm) attained in Functional Reach Test.
4 months
Change the Unipedal Stance Test performance
Change the time (s) in left and right unipedal stance.
4 months
Change the Static Full Tandem Test performance
Change the time (s) in full-tandem position.
4 months
Change the Walking Full Tandem Test performance
Achieve at least 10 steps in full-tandem.
4 months
Change the Time Up and Go Test performance
Change the time (s) in performing the Time Up and Go test.
4 months
Change the 6 minutes walk test performance
Change the distance (m) covered for 6 minutes of walking.
4 months
Secondary Outcomes (24)
Change the Postural Stability (length displacement of Center of Pressure)
4 months
Change the Postural Stability (displacement of Center of Pressure)
4 months
Change the Postural Stability (Ellipse surface)
4 months
Change the Postural Stability (Mean Speed of Center of Pressure)
4 months
Change the Postural Stability (Standard deviation of Center of Pressure)
4 months
- +19 more secondary outcomes
Study Arms (2)
Standard Footwear (SF)
EXPERIMENTALIntervention: plantar orthoses, education on foot self-care and appropriate standard footwear.
Orthopedic Footwear (OF)
EXPERIMENTALIntervention: plantar orthoses, education on foot self-care and orthopedic footwear.
Interventions
The orthopedic footwear used by the OF Group was manufactured by the company J. Andrade Ferreira Neves Lda. with materials suitable for the diabetic foot, as registered with INFARMED under registration ID 279515.
In the SF Group, it was recommended to use standard shoes more suitable for diabetic foot, with some specific characteristics, such as sports or walking shoes. The acquisition or not of a more suitable shoes by the participants was at the discretion of each individual.
The plantar orthoses (PO) that both groups used for distribute of plantar loads was based on the principle of total contact. The confection material consisted in a liner of EVA shore 20º and polyurethane filling ELAX flexible (expandable) from OKM Química Ortopédica SL.
An information leaflet with foot care was delivered, with the aim of ensuring that participants were informed about the care they should continually take with their feet during the study period. This leaflet was created based on the guidelines of the "Associação Protetora dos Diabéticos" in Portugal.
Eligibility Criteria
You may qualify if:
- Presence of type 2 DM;
- Have at least 6 months from diagnosis of DM;
- Presence of Diabetic Polyneuropathy;
- No history of plantar orthoses and orthopedic footwear use.
You may not qualify if:
- Active ulceration;
- Severe osteoarticular deformities;
- Presence of cognitive impairment;
- Gait with technical devices;
- Diagnosis of neurological pathology that can affect the gait pattern;
- Diagnosis of another pathology that can negatively influence the study: depression, the presence of uncontrolled cardiovascular diseases and active cancer.
- Surgical interventions on the spine and lower limbs, with less than 1 year of recovery.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Universidade do Algarvelead
- University of Huelvacollaborator
- OKM Química Ortopédica S.L.collaborator
- Lola - J. Andrade Ferreira Neves Ldacollaborator
- Instituto São João de Deus (ISJD)collaborator
- Ortobalance - Ortopedia Técnica e Desportivacollaborator
- Sensor Médicacollaborator
- Pierre Fabre Portugalcollaborator
- Associação para o Estudo da Diabetes Mellitus e de Apoio ao Diabético do Algarve (AEDMADA)collaborator
- Unidade Funcional de Faro - Agrupamento de Centros de Saúde do Centralcollaborator
Study Sites (1)
Marta Botelho
Faro, Algarve, 8005-139, Portugal
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Marta Botelho, PhD
Researcher
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research Fellowship
Study Record Dates
First Submitted
October 15, 2020
First Posted
October 28, 2020
Study Start
March 13, 2017
Primary Completion
January 4, 2018
Study Completion
May 21, 2018
Last Updated
October 30, 2020
Record last verified: 2020-10